MedScapeIndia-AMET Organises 6th FIT INDIA Conclave 2023

Our Bureau

MedScapeIndia-AMET broke new ground in Indian healthcare with its 6th Fit India Conclave 2023, a crucial initiative for nationwide CPR training and the all-inclusive Health4All goal. This year’s conclave addressed the escalating concerns around India’s preventive healthcare and emphasized the need for accessibility to crucial life-saving techniques like CPR. With cardiovascular diseases being a major health concern in India, this initiative could potentially save countless lives and significantly enhance India’s emergency response capacity.

The conclave also proposed a landmark bill to safeguard doctors against assaults, reflecting a necessary shift towards ensuring safety and respect for healthcare professionals. The rising cases of doctor-patient conflicts and violence against medical practitioners have underscored the urgency of such a legislation. The proposed bill could become a pivotal step towards establishing a safer, more harmonious healthcare environment.

Promoting inclusivity in health initiatives, the conclave launched the Girl Child Anthem, emphasizing the need to address the health concerns of the often marginalized girl children in India. This focus on inclusivity reinforced the event’s overarching theme of Health4All, reminding attendees that true health equality can only be achieved when every segment of the population is accounted for.

As Shri Lakshman Prasad Acharya, the Governor of Sikkim, lauded the efforts of Team MedScapeIndia, the 6th Fit India Conclave highlighted the power of collective action in healthcare. The drive towards achieving a healthier India will need every citizen’s contribution, and events like these serve as a strong reminder of our shared responsibility towards our nation’s health and wellness.

Author

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Syngene to acquire multi-modal facility from Stelis Biopharma Ltd, adding 20,000 liters of installed biologics drug substance manufacturing capacity, with scope for further expansion, and a high speed, commercial scale, fill-finish unit

Syngene today announced the acquisition of Unit 3 biologics manufacturing facility in Bangalore, India, from Stelis Biopharma Limited (SBL). The companies have entered into a binding term sheet and, on completion of the transaction, the site will add 20,000 liters of installed biologics drug substance manufacturing capacity for Syngene. The […]
"Syngene acquisition of Unit 3 biologics manufacturing facility in Bangalore"

Subscribe Now